Autopsy report · NCT01026090
Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)
Cause of deathFunding or business, also slow enrollment
“'Sponsor decision following recruitment issues, not related to any safety concerns in the study”
Life of this trial
- Ran for about 2 years 1 month before it stopped.
- 292 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Atrial Fibrillation
- Interventions
- Dronedarone; Placebo (for dronedarone)
- Participants
- 292
- Sites
- 43
- Countries
- Canada
Trials that died the same way
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
“Sponsor decision, not related to safety concerns” - Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
“Sponsor decision not related to safety reasons” - Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test
“The study recruited no participants due to a pre-recruitment decision by the sponsor to not proceed. Factors considered included logistics, resources, and new research data.” - A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts
“Sponsor decision, not safety related” - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
“Sponsor decision; the decision is not related to any safety concern.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.